DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ...

One of the reasons that Black children have higher rates of asthma is their comorbid conditions. For instance, obesity is ...

The study that Community Health Center patients, like Cridele, have been participating in seeks to alleviate the strain on rural patients by testing their lung performance at home, with a mobile ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

Patients with asthma who switched biologics multiple times were younger, more likely to identify as Black, and had more ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

Introduction Allergies and asthma are prevalent health issues that affect millions of people in the United States, including ...